Life Stem Genetics has new stock symbol and new financing commitmentadmin
Life Stem Genetics has new stock symbol and new financing commitment
Los Angeles, CA US, October 19, 2013 /FSC/ – Life Stem Genetics Inc. (LIFS – OTCBB), (the “Company”), an emerging innovator in the advancement of Adult Stem Cell therapy announces that the Company’s new stock symbol, LIFS, is now active.
The Company is also pleased to release the general details of its recent financing commitment. This financing is for $1 million (the “Private Placement”) of 1,000,000 units (each, a “Unit”) at a price of $1 per Unit. Each Unit will consist of one common share of the Company and one warrant to purchase an additional common share of the Company (each, a “Warrant Share”) at $1 per Warrant Share for a period of one year. The Company is to close the Private Placement within 45 calendar days of this press release.
Gloria Simov, CEO of Life Stem Genetics, commented, “Our new trading symbol and recent financing are key components to provide future value to our shareholders and to our fulfillment of our long term objectives in the emerging Adult Stem Cell therapy industry.”
All shareholders of the Company are encouraged to view the Company’s complete filings at the following link:
http://www.sec.gov/cgi-bin/browse-edgar?company=Life+Stem+Genetics HYPERLINK “http://www.sec.gov/cgi-bin/browse-edgar?company=Life+Stem+Genetics&owner=exclude&action=getcompany”& HYPERLINK “http://www.sec.gov/cgi-bin/browse-edgar?company=Life+Stem+Genetics&owner=exclude&action=getcompany”owner=exclude HYPERLINK “http://www.sec.gov/cgi-bin/browse-edgar?company=Life+Stem+Genetics&owner=exclude&action=getcompany”& HYPERLINK “http://www.sec.gov/cgi-bin/browse-edgar?company=Life+Stem+Genetics&owner=exclude&action=getcompany”action=getcompany
About Life Stem Genetics
Life Stem Genetics (“LSG”) is a progressive health care company that focuses on healing with a patient’s own “Stem Cells”. Stem Cells for years have been known to heal a variety of ailments successfully and now it is being offered as an efficient and painless way to treat many different illnesses ranging from orthopedic Injuries, neurological disorders such as Parkinson’s, and Alzheimer’s, Cancer, Plastic Surgery, Age Management, Arthritis, Diabetes, Cardiology, COPD, MS, Urology, and many more. Stem Cell Therapy and LSG’s proprietary techniques have experienced some of the best results in the industry, helping to repair or re-program damaged or diseased tissues and organs.
LSG’s stem cell specialist has performed thousands of stem cell treatments, including the top names in PGA golf, NFL football, NBA basketball, and Major League Baseball. LSG will offer their proprietary treatments through a series of affiliate doctors, and medical clinics, with 60 affiliated clinics so far.
LSG’s mission is to create a solid comprehensive approach to the treatment and maintenance of diseases and to break free from the medical insurance world by tapping into an affordable private- pay sector delivering exceptional healthcare free from the medical insurance maze.
Contact: Scott Fraser 310-279-5234
This press release contains “forward-looking statements” within the meaning of the “safe-harbor” provisions of the Private Securities Litigation Reform Act of 1995 that are not historical facts. These statements can be identified by the use of forward-looking terminology such as “believe,” “expect,” “may”, “could”, “estimates”, “will,” “should,” “project,” “plan,” “seek,” “intend,” or “anticipate” or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and the Company’s future performance, operations, and products. Such statements involve known and unknown risks, uncertainties and other factors that could cause the Company’s actual results to differ materially from the results expressed or implied by such statements. Such risks and uncertainties include, without limitation, market acceptance of the Company’s stem cell therapy treatment program; the Company’s compliance with applicable statutes and regulations: the Company’s reliance on third-party contractors to provide suitable treatment facilities; the Company’s ability to expand its network of participating clinics and doctors; the Company’s ability to develop an effective marketing strategy; the Company’s ability to control and reduce advertising and marketing costs; the Company’s ability to develop and increase awareness of its brand; the Company’s ability to protect its trademarks; and the success of the Company’s marketing focus to patients, doctors and clinics. For a discussion of these and other risks and uncertainties see “Risk Factors” and “Description of Business” in the Company’s public filings with the SEC. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company has no obligation to update the forward-looking information contained in this press release.
To view this press release as a PDF file click onto the following link:
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Posted: October 19th, 2013 under FSCWIRE.